ストックスクリーナーアプリを入手
8.56
1.27%
-0.11
アフターアワーズ：
8.66
0.10
+1.17%
Novavax Inc (NVAX) 最新ニュース
Novavax Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Novavax (NVAX) Shares Decline Amid Transition to Royalty Model - GuruFocus
Novavax rises after six sessions of decline - MSN
Novavax set for a seventh straight decline - MSN
(NVAX) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Novavax Q4 Earnings Preview: Wall Street Expects Wider Losses Amid Diversification Efforts - Stocktwits
Novavax Inc. stock underperforms Monday when compared to competitors - MarketWatch
Novavax (NVAX) up 10.4% since last earnings report: Can it continue? - MSN
Novavax, Inc. (NVAX) is attracting investor attention: Here is what you should know - MSN
Novavax, Inc. (NVAX) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance Singapore
NVAX Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Novavax Q1 2026 slides: partnership revenue surges amid strategic shift - Investing.com
Earnings call transcript: Novavax Q1 2026 beats forecasts, stock surges - Investing.com
Novavax Inc. stock underperforms Friday when compared to competitors - MarketWatch
Novavax Inc stock (US6707721049): Q1 2026 results and valuation metrics in focus - AD HOC NEWS
Novavax Stock Hits Over 1-Year High: Is Sanofi’s Flu-COVID Shot The Post-Pandemic Growth Driver? - Stocktwits
Novavax, Inc. Trade Ideas — BSESOF:NVV1 - TradingView
Novavax (NVAX) Up 10.4% Since Last Earnings Report: Can It Continue? - Yahoo Finance
Novavax Swings To Profit In Q4 Fueled By Nuvaxovid-Linked Revenue - Stocktwits
Novavax beats first-quarter revenue estimates on strength in vaccine deals - marketscreener.com
Novo Nordisk opens Czech facility for obesity drugs - marketscreener.com
Novavax rises after strong Q1 beat driven by Pfizer deal - MSN
NVAX Technical Analysis | Trend, Signals & Chart Patterns | NOVAVAX INC (NASDAQ:NVAX) - ChartMill
Novavax Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Deadline in 2 Days: Kessler Topaz Meltzer & Check, LLP Reminds Novavax, Inc. (NVAX) Investors of Filing Deadline in Class Action Lawsuit and Encourages Investors with Substantial Losses to Contact the Firm - TMX Newsfile
Novavax to Participate in 2026 Jefferies Global Healthcare Confe - GuruFocus
Novavax to Participate in 2026 Jefferies Global Healthcare Conference - PR Newswire
Novavax Inc stock (US6707721049): Analyst consensus points to hold as NVAX trades near 11 USD - AD HOC NEWS
Novavax fireside chat at 2026 Jefferies Global Healthcare Conference - Stock Titan
Novavax Stock Soars 13.57%, Hits Intraday High of $10.52 - Markets Mojo
Novavax: The Pivot To A Royalty Model Is Working, But It's Still A Hold (NASDAQ:NVAX) - Seeking Alpha
Novavax Inc. stock outperforms competitors on strong trading day - MarketWatch
Liquidity Mapping Around (NVAX) Price Events - Stock Traders Daily
NVAX News | NOVAVAX INC (NASDAQ:NVAX) - ChartMill
Novavax Inc stock (US6707721049): shares trade around USD 10 after recent volatility and licensing f - AD HOC NEWS
Novavax Inc. stock underperforms Thursday when compared to competitors - MarketWatch
FDA advisers recommend COVID vaccines be updated to target current dominant variant - Reuters
Novavax Inc stock (US66987V1098): NVAX trades at $11.09 on Nasdaq - AD HOC NEWS
R. Draghia Akli sells 30,000 NVAX shares (NASDAQ: NVAX) - Stock Titan
Why Novavax (NVAX) Stock Is Trading Up Today - Yahoo Finance
US FDA advisers to weigh updating 2026-27 COVID vaccines to target XFG variant - Reuters
Novavax, Inc. (NVAX) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance
3 Reasons NVAX is Risky and 1 Stock to Buy Instead - Yahoo Finance
Operating margin % of Novavax, Inc. – BSESOF:NVV1 - TradingView
Small-Cap Stocks to Avoid: Peloton, Novavax, and BKV Face Financial RisksNews and Statistics - IndexBox
Why (NVAX) Price Action Is Critical for Tactical Trading - Stock Traders Daily
Assessing Novavax (NVAX) Valuation As Trading Swings Revive Investor Interest - Yahoo Finance
2.20%
2.09%
大文字化:
|
ボリューム (24 時間):